The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
methyl (4-((2-amino-6-methyl-4-oxo-3,4-dihydroquinazolin-5-yl)thio)benzoyl)-L-tyrosinate ID: ALA5268759
Max Phase: Preclinical
Molecular Formula: C26H24N4O5S
Molecular Weight: 504.57
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1ccc(Sc2c(C)ccc3nc(N)[nH]c(=O)c23)cc1
Standard InChI: InChI=1S/C26H24N4O5S/c1-14-3-12-19-21(24(33)30-26(27)29-19)22(14)36-18-10-6-16(7-11-18)23(32)28-20(25(34)35-2)13-15-4-8-17(31)9-5-15/h3-12,20,31H,13H2,1-2H3,(H,28,32)(H3,27,29,30,33)/t20-/m0/s1
Standard InChI Key: XITZPKRBIJKKSJ-FQEVSTJZSA-N
Molfile:
RDKit 2D
36 39 0 0 0 0 0 0 0 0999 V2000
3.2052 -1.8614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2052 -1.0364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9168 -0.6258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6257 -1.0359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6257 -1.8577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9186 -2.2678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3371 -2.2685 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4938 -0.6256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7823 -1.0364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7823 -1.8579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5068 -2.2761 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0621 -2.2515 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0621 -3.0728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0709 -0.6256 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3595 -1.0364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3595 -1.8579 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3519 -0.6256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0590 -1.0357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7724 -0.6293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7724 0.1956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4838 0.6064 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.4838 1.4278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1970 1.8341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1970 2.6589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9144 3.0728 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.6257 2.6563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6257 1.8357 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.9093 1.4234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9093 0.6020 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.3371 3.0671 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4856 3.0693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7769 2.6593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7769 1.8378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0655 1.4271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0608 0.6062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3519 0.1960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
4 3 1 0
5 4 2 0
6 5 1 0
1 6 2 0
5 7 1 0
8 2 1 0
9 8 1 0
9 10 1 1
10 11 2 0
10 12 1 0
12 13 1 0
14 9 1 0
15 14 1 0
15 16 2 0
17 15 1 0
18 17 1 0
19 18 2 0
20 19 1 0
21 20 1 0
22 21 1 0
23 22 2 0
24 23 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 1 0
23 28 1 0
28 29 2 0
26 30 1 0
31 24 2 0
32 31 1 0
33 32 2 0
22 33 1 0
33 34 1 0
35 20 2 0
36 35 1 0
17 36 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 504.57Molecular Weight (Monoisotopic): 504.1467AlogP: 3.18#Rotatable Bonds: 7Polar Surface Area: 147.40Molecular Species: NEUTRALHBA: 8HBD: 4#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.50CX Basic pKa: 3.40CX LogP: 3.82CX LogD: 3.82Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.28Np Likeness Score: -0.40
References 1. Alagarsamy V, Chitra K, Saravanan G, Solomon VR, Sulthana MT, Narendhar B.. (2018) An overview of quinazolines: Pharmacological significance and recent developments., 151 [PMID:29656203 ] [10.1016/j.ejmech.2018.03.076 ]